Is Mylanta Contraindicated After CABG Surgery?
No, Mylanta (aluminum/magnesium hydroxide antacid) is not contraindicated after CABG (coronary artery bypass graft) surgery, but it requires careful consideration of renal function and should be avoided in patients with significant kidney impairment.
Key Considerations for Antacid Use Post-CABG
Renal Function Assessment
- Aluminum hydroxide is contraindicated in severe renal impairment (creatinine clearance <10 mL/min) due to risk of aluminum accumulation and toxicity 1
- Patients with moderate renal impairment (creatinine clearance 10-35 mL/min) should avoid aluminum-containing antacids as they are "not recommended" in this population 1
- CABG patients frequently have underlying chronic kidney disease or develop acute kidney injury perioperatively, making renal function assessment critical before prescribing aluminum-containing products
Aluminum Toxicity Risk
- Aluminum accumulation can occur with chronic use, particularly when renal clearance is impaired 1
- Toxicity manifests as bone disease, neurological symptoms, and hypocalcemia 1
- The cumulative dose of aluminum is a continuous variable predicting risk—even "safe" doses (30 mg/kg) in patients with kidney disease showed significant plasma aluminum increases within 4 months 1
Drug Interactions
- Mylanta can reduce absorption of multiple medications commonly used post-CABG, including certain antibiotics, anticoagulants, and cardiovascular medications 2
- The aluminum and magnesium components can form complexes with other drugs, reducing their bioavailability 2
Safer Alternatives Post-CABG
Preferred Options
- Proton pump inhibitors (PPIs) are the preferred agents for gastric acid suppression in critically ill patients, including post-cardiac surgery 1
- H2-receptor antagonists (e.g., famotidine) are significantly more effective than antacids like Mylanta for maintaining gastric pH >4 in critically ill patients 3
- Famotidine 20 mg IV every 12 hours maintains better pH control (median pH 7.8 in antrum) compared to Mylanta 30 mL every 2 hours (median pH 4.5) 3
Clinical Pitfalls to Avoid
- Do not assume "antacids are safe" without checking renal function—aluminum toxicity develops insidiously over months 1
- Avoid combining Mylanta with medications that have narrow therapeutic indices or require consistent absorption (warfarin, digoxin, certain antibiotics) 2
- Monitor for constipation (aluminum effect) or diarrhea (magnesium effect), which can complicate post-operative recovery
Practical Algorithm
For post-CABG patients requiring gastric acid suppression:
Check creatinine clearance first
- If CrCl <35 mL/min: Do not use Mylanta 1
- If CrCl ≥35 mL/min: Mylanta can be used short-term with caution
Assess medication list for interactions
- If taking medications requiring consistent absorption: Choose alternative (PPI or H2-blocker) 2
Consider duration of therapy
- Short-term (<2 weeks): Mylanta acceptable if renal function normal
- Long-term: Switch to PPI or H2-blocker to avoid aluminum accumulation 1
Monitor for complications
- If using >2 weeks: Check serum aluminum levels every 6 months 1
- Watch for constipation, hypophosphatemia, or neurological changes
Bottom line: While not absolutely contraindicated post-CABG, Mylanta is inferior to H2-blockers or PPIs for stress ulcer prophylaxis and carries significant risks in the renal-impaired population common after cardiac surgery. Choose famotidine or a PPI instead. 1, 3